Corrigendum: Guanxin Danshen formulation protects against myocardial ischemia reperfusion injury-induced left ventricular remodeling by upregulating estrogen receptor β

In the published article, there was an error in Figure 4 as published. In Figure 4A, the “Sham” and “High dose” group inadvertently used the same representative images as those in Figure 3A. The corrected Figure 4 appears below.

FIGURE 4.

Echocardiogram parameters in MIRI-LVR rats treated with high-dose of GXDSF treated group and PHTPP. The echocardiograms (A) were obtained using the Vevo 770 high-resolution imaging system. LVEF and LVFS (B) data are also shown in bar graphs. Compared with the sham group, ###P < 0.001. Compared with the MIRI-LVR model group: *P < 0.01. Compared with the high-dose of GXDSF treated group: &P < 0.05, &&P < 0.01. The data are presented as the mean ± SD (n = 10 in each group).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.